Thank you for the submission of your manuscript to EMBO reports. I apologize for the delay in getting back to you; we have so far only received two referee reports that are copied below. Given that both referees are in fair agreement that you should be given a chance to revise the manuscript, I would like to ask you to begin revising your manuscript along the lines suggested by the referees. Please note that this is a preliminary decision made in the interest of time, and that it is subject to change should the third referee offer very strong and convincing reasons for this. I will be in touch as soon as we will receive the final report on your manuscript.
As you will see, both referees agree that the findings are potentially interesting. However, both also point out that the data on 5hmC are not sufficiently convincing. Both referees suggest that TET3 (but not TET2 or TET1) induced changes in 5hmC at specific genes or promoters should be investigated. They also both agree that it needs to be demonstrated that miR-15b is expressed in neural progenitors, that an effect of miR-15b on neuronal migration needs to be analyzed, that exclusively cells in the VZ should be considered for an effect on proliferation, and that more details on the experimental assays and methods and quantifications/statistics need to be provided.
Given these constructive comments, we would like to invite you to revise your manuscript with the understanding that the referee concerns (as mentioned above and in their reports) must be fully addressed and their suggestions taken on board. Especially the role of TET3 and 5hmC needs to be strengthened. Acceptance of the manuscript will depend on a positive outcome of a second round of review. It is EMBO reports policy to allow a single round of revision only and acceptance or rejection of the manuscript will therefore depend on the completeness of your responses included in the next, final version of the manuscript.
Revised manuscripts should be submitted within three months of a request for revision; they will otherwise be treated as new submissions. Please contact us if a 3-months time frame is not sufficient for the revisions so that we can discuss the issue further. Also, the revised manuscript may not exceed 30,000 characters (including spaces and references) and 5 main plus 5 supplementary figures. The current character count largely exceeds our limits, and the text therefore needs to be shortened. Shortening may be made easier by combining the Results and Discussion section, which may help to eliminate some redundancy that is inevitable when discussing the same experiments twice. Commonly used materials and methods can further be moved to the supplementary information, but please note that materials and methods essential for the understanding of the experiments described in the main text must remain in the main manuscript file.
Regarding data quantification, can you please specify the number "n" for how many experiments were performed, the bars and error bars (e.g. SEM, SD) and the test used to calculate p-values (if applicable) in the respective figure legends? This information is currently missing and needs to be provided in the figure legends.
I look forward to seeing a revised version of your manuscript when it is ready. Please let me know if you have questions or comments regarding the revision.
REFEREE REPORTS:
Referee #1:
Xiahui et al. describe the function of miR-15b during corticogenesis. The authors show that its overexpression alters the fate of neural progenitors via repression of TET3 and a consequent increase in 5hmC. Hence, miR-dependent downregulation of TET3 is proposed to influence the expression of cell fate determinants via epigenetic modifications.
The topic is very interesting and timely and the finding novel, exciting and well described. Certainly there is major interest in a microRNA involved in epigenetic regulation of stemness. Overall the experimental approach is sound but I have doubts on the correctness of some sets of data, which might potentially challenge the main conclusions.
Major points, 1) The authors show that overexpression/inhibition of miR-15b alters the proportion of cells in the CP. This is shown to be due (at least in part) to a cell fate change of neural progenitors. I think this conclusion is sound but a second cause/contribution to this effect is not addressed i.e. that an altered neuronal migration might occur independently from neurogenesis. For example, if overexpression should promote neuronal migration then the authors would observe an enrichment of electroporated cells in the CP, exactly as they see. This could change the magnitude of the claimed effect on cell fate. BrdU-birthdating and quantification of BrdU+ neurons in the IZ/CP will address that. (Note that Fig 2D gives the impression that the VZ in miR-15b overexpression has a much stronger TuJ signal than control that is consistent with impaired neuronal migration.)
2) When assessing proportion of BrdU, PH3, Pax6, Tbr2, and any other marker, the authors should indicate precisely what cell population is being defined as 100%. The reference population must not always be the same. In contrast, in the current manuscript all bar graphs throughout the study use "TOTAL GFP+" as the reference population. I suspect this might be a labeling mistake because such an approach is wrong. For example, if the authors want to assess cell cycle features of progenitors then BrdU/PH3 should be referred to the subpopulation of GFP+ that are progenitors, thus excluding neurons. Otherwise it is clear that any change in the proportion of neurons would by itself change BrdU independently from cell cycle effects of progenitors. This could be done by simply counting those GFP+ that reside within the VZ/SVZ. Similarly, in counting how many apical progenitors generate basal progenitors, the reference population has to be limited to the VZ (excluding the SVZ) because this is where basal progenitors are generated; and so forth.
3) It is important in the frame of this study to show whether miR15b is physiologically expressed by progenitors. The authors show the expression profile of this miR during development (Fig. 1A and B) but these data were obtained from whole brains. Based on that alone it is possible to speculate that miR-15b is transiently expressed in newborn neurons, downregulated in mature neurons and never expressed in progenitors. Such profile will also show a peak during the peak of neurogenesis (E15) and a decrease at later time points (E18) as neurons maturate. Cell-type specificity can easily be achieved by LNA-in situ hybridization. Is miR-15b more strongly expressed by apical or basal progenitors?
4) The claim on increased 5hmC is based on immunocytochemistry that is not shown (only bar graph quantifications are shown). Being the core of the study, the readers must be given the chance to judge by themselves the quality of these stainings so pictures must be included. Moreover, it is unclear why this was not done in vivo on GFP+ cells of electroporated brains rather than in cell cultures. Finally, I could not find how this quantification of signal was done...on the whole population of cells, averaging single cells, quantifying nuclear signal, FACS, confocal sections, else? The authors should also consider quantifying this by a more robust and quantitative method than immunocytochemistry, such as ELISA or, ideally, PCR or sequencing (see next point).
5) The manuscript concludes claiming that miR15b/TET3 downregulate PCNA and Ki67. Clearly, considering their effects on the fate of progenitors and overproduction of neurons, it is entirely expected that proliferation markers would also decrease. As it is, this finding is nothing different from showing a decrease in BrdU or PH3, which were already shown. The key question at this point of the study is another one, i.e. whether TET3 directly binds and hydroxymethylate the genomic loci of PCNA and Ki67, hence epigenetically controlling their expression and influencing cell fate. This direct interaction and epigenetic change of targets is what the authors should really aim to. I fully appreciate that this might be a tricky thing to do but it would add so much that it seems worth a try.
As one suggestion the authors should consider manipulating miR15b/TET3, extract genomic DNA, use one of the kits available to discriminate 5mC from 5hmC (e.g. EpiMark, EpiJet or others), and (q-)PCR or sequence the hydroxyl-converted DNA using primers for PCNA or Ki67 to quantify 5hmC relative to 5mC in those specific targets. Again, this is not afternoon experiment and it may require serious troubleshooting and smart design of primers. If this should not be feasible, then the last section of the manuscript should be rewritten or moved to another section because in the current form it seriously misleads the reader to implicitly conclude that PCNA and Ki67 are somehow direct targets of TET3, which cannot be said at this point.
Minor points 1) I could not find which kind of miR-inhibitor the authors used. Is this a LNA, antagomir, anti-miR else??? Also, I do not understand how could the authors have obtained the data in Fig. 4E . Most miR-inhibitors block the activity of a miR by complementarity, hence competing for binding and protecting the target, but without changing the abundance of the physiological miR. Since the authors quantify by PCR, no effect should follow. Could the authors also comment on the possibility of miR-15b targeting other TETs such as 1 and 2.
2) The results open with the statement that "7 miRNAs were identified by proliferation and differentiation experiments in vitro". It would be kind to the reader to explain what experiments were done and what kind of results led to the identification of these 7. Alternatively, that sentence can go, as it says absolutely nothing.
3) Was the EdU in page 7 given for the same time as the BrdU in the previous exp?
4) There is a claim on glia (presumably astrocytes) in page 8 but GFAP in these conditions might not necessarily distinguish progenitors from differentiated astrocytes. If gliogenesis is important it should be addressed in vivo on the same electroporated brains but using other markers (such as Olig2 at this stage).
5) The colors of the bars in the graphs of supplementary material seem a piece of modern art :-) One consistent color for all controls and one for all overexpression would be more parsimonious.
Referee #2:
This is an interesting manuscript describing the function of mir15b in cerebral cortex development. The authors show that Mir15b promotes neuronal differentiation by in utero electroporation and its inhibition does the opposite. Mir15b targets tet3 and the authors then suggest that Tet3 regulation is a key factor mediating the effects of mir15b. However, the data shown on 5hmC are not convincing so far, and given that 5hmC is highest in differentiating neurons, it is difficult to grasp the overall concept how its inhibition could cause improved neuronal differentiation. Clearly the authors show that tet3 electroporation promotes proliferation, but how does it do so? These major holes in the concept need to be closed prior to publication, e.g. by showing altered levels of 5hmC at specific neuronal genes and showing that tet1 or 2 electroporation does not have the same effects. It would also be important to understand the long-term effects of these alterations -what happens after conditional deletion of tet3? Fig.2. 3) The culture experiments described on p.6 should be done in the absence of EGF/FGF2 as these factors obviously override the normal behavior of stem cells. 4) For double-stainings in Fig.2 and 3 please show Z-projections to ensure co-localization of the markers. How was the counting done to ensure this? 5) p.11: The authors cite Suppl. Fig. 4A as evidence for miR 15b affecting 5hmC levels , but I guess they refer toSuppl. Fig. 3 .
Correspondence -editor 16 Juni 2014
This is a quick note that we have contacted the referee who has not sent his/her report multiple times now, without success. I therefore suggest that we proceed with the two reports we have and that you address the concerns to the best of your abilities. I am sorry for this unusual situation.
1st Revision -authors' response 18 August 2014
Response to the comments of editor
Thank you for your valuable comments. They will be very good to our manuscript. Thank you for your suggestions again.
----
Response to the comments of reviewer # 1
Thank you for giving us so much valuable and positive comments, they will make our manuscript and research work better. The specific reply for the comments is as follows. Fig S1A--D) . This demonstrates that neuronal migration is a cause (at least in part) to the changed proportion of cells in the cortex following miR--15b alteration.
However, the contribution of neuronal migration is less compared with the cell fate change of neural progenitor from the results of statistical analysis. The modification is also shown in the Results part. In addition, we have replaced the Fig 2D (miR--15b ).
2. According to your suggestions, we have indicated the reference population. The modification has been shown in the figures. We want to examine the effects of miR--15b on the relative proportions of apical and basal progenitors in Fig  3, but not how many apical progenitors generate basal progenitors. Thank you for this suggestion.
3. According to your suggestion, we performed the in situ hybridization to examine the expression of miR--15b. The results displayed higher expression of miR--15b in the CP and SVZ/VZ in the developing cortex but lower in the IZ (Fig 1C) . To further confirm the expression of miR15b in NPCs, we performed the double immunostaining experiments.
We noted that miR--15b more strongly expressed in Pax6--positive apical progenitors, whereas in Tbr2--positive basal progenitors (Fig 1D, E) .
4. According to this suggestion, we used the dot blot to detect the change of 5hmC and 5mC levels. Dot blot analysis revealed that 5hmC levels altered following miR--15b expression, whereas 5mC levels did not change significantly (Fig 4F--I ). In addition, the immunostaining experiments in vitro and in vivo showed similar results ( Supplementary   Fig S3A--C) . ( Fig 4L) . GlucMS--qPCR assay showed that the correlated changes of methylation and hydroxylation at cyclin D1 loci after TET3 knockdown (Fig 4M) . TET3 inhibition caused the decrease of 5mC hydroxylation. Thanks for this suggestion. In addition, we also tested whether miR--15b targeted TET1 and TET2. The possibility was ruled out by target prediction analysis and the results that no significant changes of TET1 and TET2 mRNA levels following miR--15b manipulation (Fig  A  and  B  as follows).
7. According to your suggestion, we have deleted the sentence "7 miRNAs were identified by proliferation and differentiation experiments in vitro". Thank you for your suggestions again.
Response to the comments of reviewer # 2
Thank you for giving us these valuable comments, and they will give us great help to our manuscript and research work in the future. The specific reply for the comments is as follows.
Response to your general suggestions:
According to your suggestions, we did the dot blot experiment to detect the change of 5hmC and 5mC levels. Dot blot analysis revealed that 5hmC levels altered following miR--15b expression, whereas 5mC levels did not change significantly (Fig 4F--I . ChIP assay showed that TET3 directly bound to the promoter of cyclin D1 (Fig 4L) . GlucMS--qPCR assay showed that the correlated changes of methylation and hydroxylation at cyclin D1 loci after TET3 knockdown in NPCs (Fig 4M) .
TET3 inhibition caused the decrease of 5mC hydroxylation, hence epigenetically controlling the expression of cyclin D1 and influencing cell fate. In addition, we also tested whether miR--15b targeted TET1 and TET2. The possibility was ruled out by target prediction analysis and the results showed no significant changes of TET1 and TET2 mRNA levels following miR--15b manipulation (Fig A and B as follows) . Our current work mainly focuses on the effects of miR--15b on the neural progenitor proliferation during early neocortical development. The results showed that TET3 was the direct target of miR--15b, and its expression and 5hmC levels were regulated by miR--15b. We performed in utero electroporation for overexpression or knockdown of TET3. Importantly, TET3 rescued the miR--15b--induced proliferation defects, and the miR--15b/TET3 interaction was involved in NPC proliferation. As for the long--term effects of these alterations after conditional deletion of TET3 need further and more work.
Thank you for the submission of your revised manuscript to our journal. We have now received the enclosed report from one of the two referees. Given that the comments of both referees largely overlap, and that referee 1 now supports publication of the manuscript, we can offer to publish it. However, referee 1 also has a few suggestions for how the data presentation can be improved and asks for one addition to figure 4M, which should be addressed and incorporated before we can proceed with the official acceptance of your manuscript.
I further noticed that the materials and methods section is very short now. Can you please include a short version of the most important methods (may be the in vivo assays) to it? We have recently decided that length should not be a limitation for EMBO reports articles anymore, so you do not need to worry about character count. However, as we have not yet officially announced that EMBO reports will also publish longer articles in the future, please keep the addition to the main materials and methods short (1 or 2 paragraphs).
I look forward to seeing a newly revised version of your manuscript as soon as possible. Please let me know if you have any questions or comments.
REFEREE REPORT:
The authors have addressed essentially all my comments making it for a substantially more robust study. I only have a number of suggestions to better present the data. I believe that this will not require any experiment since this is a matter of presenting the same data in a different way.
1) Boundaries of cortical layers (primarily Fig 1) do not seem correct. I appreciate that these are estimates given the general absence of markers but a better guess could (and should) be achieved. For example, Pax6 in 1D makes it clear that the current SVZ/IZ boundary is instead the VZ/SVZ since Pax6 is not expressed in the SVZ. From there, one wonders how accurate are the quantifications in other panels, such as 1G. I believe this will not change significantly the outcome of the study. Yet, more accurate quantifications seem doable and appropriate.
2) It would be preferable to show the single channels of miR-15 FISH in 1D-E (and whenever possible). On the merge it's hard-to-impossible to judge colocalization.
3) Although my comment on neuronal migration is addressed, the type of quantification provided is partly incomplete. In addition to distribution between layers it would be good to also measure distribution within a single layer. Specifically, I suggest to split the CP in equidistant bins (say 5 or 10) and then calculate the distribution of he BrdU+/GFP+ cells within those bins. This will provide a clearer picture and can be done on available pictures. Fig 1I, the middle panel shows several PH3+ cells ectopically dividing in the middle of the VZ, which is very unusual. These cells appear to also be GFP-, which may suggest a cell-extrinsic effect. Is this real? If so, this is interesting and the authors may consider discussing that as a lead for "future studies". If not, then the picture should be replaced with a more representative one.
4)
5) It's unclear if quantifications in Fig 2A were performed taking GFP+ cells of the entire cortex or only VZ/SVZ as in the pictures (the former would not be correct since Ki67-cells are be mostly located in the IZ/CP). Fig 4L, it is unclear what "relative" refers to. In the legend and methods we read that ChIP data were normalised to tubulin. However, since IP is done on TET it is obvious that RNAi will necessarily lead to less TET being IP... hence, less cylinD1 promoter binding relative to tubulin. I believe that normalization should be done relative to the TET protein being detected after RNAi, in addition to tubulin, to have a guess of the amount of cyclin promoter being retrieved relative to the amount of TET present. Am I correct?
6)
7) The authors should extend 4M to include 5mC upon miR-15 overexpression. This is the whole point of the study being TET the "intermediate between the two".
Lastly, the authors may wish to discuss the recent link between cyclin D expression and miRNA networks (Ghosh, Cell Rep) and although generally improved, the English still needs some revision as several sentences make grammatically no sense, e. Response to the comments of reviewer # 1
Thank you for giving us these comments, they will make our manuscript better. The specific reply for the comments is as follows.
overexpression. The result has been shown in Fig 4N. 8. According to your suggestion, we have added discuss about the recent link between cyclin D1 expression and miRNA networks. In addition, the English of the sentences you mentioned has been further revised. The modification has been shown by colored text.
Thank you for your suggestions again.
3rd Editorial Decision 22 September 2014
I am very pleased to accept your manuscript for publication in the next available issue of EMBO reports. Thank you for your contribution to our journal. Please find below the referee comments on the revised manuscript, and please address them by revising the manuscript text. You can send us a new version of the text and we will replace the current version for you.
Thank you again for your contribution to EMBO reports and congratulations on a successful publication. Please consider us again in the future for your most exciting work.
REFREE REPORT:
Referee 1:
The authors have addressed all my comments. the study is complete as it is. i only suggest some minor editing of the text. i hope the authors are able to identify the parts in the text to which the list below refers to
Introduction: "almost all of these neurons..."; change to "All these neurons..."
"important parts" > "important roles"
Results "miR-15b was identified to have the most significant effects..." > "....to display the most significant changes in expression levels during early ..."
"However, the contribution of neuronal migration is less compared with the cell fate change of neural progenitor from the results of statistical analysis.". This is not a contraddiction (remove "however"), these are just two different effects "performed an analysis of cell-cycle exit and the result..." Describe the experiment in the text such that it is possible to understand what the authors have done without the need to interrupt the reading to go to material and methods or figure legends to understand. this is recurrent in several parts of the text! "decreased the number of cells passing through S phase". Careful, all cells may go through S, this number is not necessarily changed. The data represent "the proportion of time that cells have spent in S phase", that is, G1 is now becoming longer symmetrical > symmetric "to produce miR-15b overexpression or inhibition conditions" > "to overexpress or inhibit miR" reference 34 in the text is misplaced
